Cargando…
Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability
Systemic inflammation co-activates coagulation, which unchecked culminates in a lethal syndrome of multi-organ microvascular thrombosis known as disseminated intravascular coagulation (DIC). We studied an endotoxin-induced inflammatory state in rats to identify biomarkers of hemostatic imbalance fav...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233421/ https://www.ncbi.nlm.nih.gov/pubmed/28081568 http://dx.doi.org/10.1371/journal.pone.0169976 |
_version_ | 1782494864438460416 |
---|---|
author | Brooks, Marjory B. Turk, James R. Guerrero, Abraham Narayanan, Padma K. Nolan, John P. Besteman, Elizabeth G. Wilson, Dennis W. Thomas, Roberta A. Fishman, Cindy E. Thompson, Karol L. Ellinger-Ziegelbauer, Heidrun Pierson, Jennifer B. Paulman, April Chiang, Alan Y. Schultze, Albert E. |
author_facet | Brooks, Marjory B. Turk, James R. Guerrero, Abraham Narayanan, Padma K. Nolan, John P. Besteman, Elizabeth G. Wilson, Dennis W. Thomas, Roberta A. Fishman, Cindy E. Thompson, Karol L. Ellinger-Ziegelbauer, Heidrun Pierson, Jennifer B. Paulman, April Chiang, Alan Y. Schultze, Albert E. |
author_sort | Brooks, Marjory B. |
collection | PubMed |
description | Systemic inflammation co-activates coagulation, which unchecked culminates in a lethal syndrome of multi-organ microvascular thrombosis known as disseminated intravascular coagulation (DIC). We studied an endotoxin-induced inflammatory state in rats to identify biomarkers of hemostatic imbalance favoring hypercoagulability. Intraperitoneal injection of LPS at 15 mg/kg body weight resulted in peripheral leukopenia and widespread neutrophilic sequestration characteristic of an acute systemic inflammatory response. Early indicators of hemostatic pathway activation developed within 4 hours, including increased circulating concentrations of procoagulant extracellular vesicles (EVs), EVs expressing endothelial cell and platelet membrane markers, and high concentration of soluble intercellular adhesion molecule-1 (sICAM-1), plasminogen activator inhibitor-1 (PAI-1), and D-dimers. Inflammation persisted throughout the 48-hour observation period; however, increases were found in a subset of serum microRNA (miRNA) that coincided with gradual resolution of hemostatic protein abnormalities and reduction in EV counts. Dose-adjusted LPS treatment in rats provides a time-course model to develop biomarker profiles reflecting procoagulant imbalance and rebalance under inflammatory conditions. |
format | Online Article Text |
id | pubmed-5233421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-52334212017-01-31 Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability Brooks, Marjory B. Turk, James R. Guerrero, Abraham Narayanan, Padma K. Nolan, John P. Besteman, Elizabeth G. Wilson, Dennis W. Thomas, Roberta A. Fishman, Cindy E. Thompson, Karol L. Ellinger-Ziegelbauer, Heidrun Pierson, Jennifer B. Paulman, April Chiang, Alan Y. Schultze, Albert E. PLoS One Research Article Systemic inflammation co-activates coagulation, which unchecked culminates in a lethal syndrome of multi-organ microvascular thrombosis known as disseminated intravascular coagulation (DIC). We studied an endotoxin-induced inflammatory state in rats to identify biomarkers of hemostatic imbalance favoring hypercoagulability. Intraperitoneal injection of LPS at 15 mg/kg body weight resulted in peripheral leukopenia and widespread neutrophilic sequestration characteristic of an acute systemic inflammatory response. Early indicators of hemostatic pathway activation developed within 4 hours, including increased circulating concentrations of procoagulant extracellular vesicles (EVs), EVs expressing endothelial cell and platelet membrane markers, and high concentration of soluble intercellular adhesion molecule-1 (sICAM-1), plasminogen activator inhibitor-1 (PAI-1), and D-dimers. Inflammation persisted throughout the 48-hour observation period; however, increases were found in a subset of serum microRNA (miRNA) that coincided with gradual resolution of hemostatic protein abnormalities and reduction in EV counts. Dose-adjusted LPS treatment in rats provides a time-course model to develop biomarker profiles reflecting procoagulant imbalance and rebalance under inflammatory conditions. Public Library of Science 2017-01-12 /pmc/articles/PMC5233421/ /pubmed/28081568 http://dx.doi.org/10.1371/journal.pone.0169976 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Brooks, Marjory B. Turk, James R. Guerrero, Abraham Narayanan, Padma K. Nolan, John P. Besteman, Elizabeth G. Wilson, Dennis W. Thomas, Roberta A. Fishman, Cindy E. Thompson, Karol L. Ellinger-Ziegelbauer, Heidrun Pierson, Jennifer B. Paulman, April Chiang, Alan Y. Schultze, Albert E. Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability |
title | Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability |
title_full | Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability |
title_fullStr | Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability |
title_full_unstemmed | Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability |
title_short | Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability |
title_sort | non-lethal endotoxin injection: a rat model of hypercoagulability |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233421/ https://www.ncbi.nlm.nih.gov/pubmed/28081568 http://dx.doi.org/10.1371/journal.pone.0169976 |
work_keys_str_mv | AT brooksmarjoryb nonlethalendotoxininjectionaratmodelofhypercoagulability AT turkjamesr nonlethalendotoxininjectionaratmodelofhypercoagulability AT guerreroabraham nonlethalendotoxininjectionaratmodelofhypercoagulability AT narayananpadmak nonlethalendotoxininjectionaratmodelofhypercoagulability AT nolanjohnp nonlethalendotoxininjectionaratmodelofhypercoagulability AT bestemanelizabethg nonlethalendotoxininjectionaratmodelofhypercoagulability AT wilsondennisw nonlethalendotoxininjectionaratmodelofhypercoagulability AT thomasrobertaa nonlethalendotoxininjectionaratmodelofhypercoagulability AT fishmancindye nonlethalendotoxininjectionaratmodelofhypercoagulability AT thompsonkaroll nonlethalendotoxininjectionaratmodelofhypercoagulability AT ellingerziegelbauerheidrun nonlethalendotoxininjectionaratmodelofhypercoagulability AT piersonjenniferb nonlethalendotoxininjectionaratmodelofhypercoagulability AT paulmanapril nonlethalendotoxininjectionaratmodelofhypercoagulability AT chiangalany nonlethalendotoxininjectionaratmodelofhypercoagulability AT schultzealberte nonlethalendotoxininjectionaratmodelofhypercoagulability |